SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.18-2.5%Dec 1 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (4011)6/6/2001 9:05:14 AM
From: Biomaven  Read Replies (1) of 52153
 
V1,

Biotech momentum is back.

Yes, and so are the stock offerings. SCIO (understandable), CORR (incomprehensible), ITMN, ARNA, etc. Enough offerings and we'll likely damp down the momentum.

(BTW, for newcomers, biotech offerings are typically posted and commented on in the following excellent thread:

Subject 19115 )

Lots of comments of late that biotechs' "warning season" consists of upward surprises. So I wouldn't be surprised to see strength in the upper tier biotechs here as we get refugees from the tech stocks.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News